Tobias Geisler
Tobias Geisler is an expert in Cardiology at Universitätsklinikum Tübingen (Germany). As of October 2026, ScienceLeadR ranks Tobias Geisler in the top 1% of experts worldwide for Embolism and Thrombosis, Myocardial Ischemia and Arrhythmias, Cardiac. Tobias Geisler has authored 434 publications, the most recent in 2026, and is an investigator in 38 clinical trials, 7 of them ongoing. SLR score: 1,935 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Hematology - Public Health - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2004 - 2026
Number : 434
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The GLIDE Score: One-Year Outcomes Following Tricuspid Transcatheter Edge-to-Edge Repair. PMID 42948575 — mortality, echocardiography | Struct Heart | 2026 | 0 |
| Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event. PMID 42670965 — safety, hemorrhage, ischemic stroke, stroke, myocardial infarction, acute coronary syndrome, therapeutics | N Engl J Med Top journal | 2026 | 5 |
| JAK3 regulates PIP5K expression, promotes PIP2 generation and Ca2+ driven platelet activation in arterial thrombosis. PMID 42766692 — hematology, protein-tyrosine kinases, phosphatidylinositol 4,5-diphosphate, janus kinases, thrombosis, blood platelets, platelet activation | Blood | 2026 | 0 |
| Tricuspid-Valve Intervention in Heart Failure. PMID 42670975 — hospitalization, heart failure, heart, tricuspid valve, therapeutics, tricuspid valve insufficiency | N Engl J Med Top journal | 2026 | 15 |
| Prognostic Value of NYHA Functional Class in Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights From EuroTR. PMID 42663375 — mortality, body mass index, hospitalization, heart failure, heart, pulmonary artery, tricuspid valve, arteries, tricuspid valve insufficiency | JACC Adv | 2026 | 0 |
Clinical Studies 38
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
7 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Trial to Test How AZD0780 Affects Serious Heart Stroke or Vascular Problems in Patients with Heart Stroke or Vascular Disease or at High Risk for Such Issues 2025-520519-14-00 — stroke, heart, cardiovascular diseases, vascular diseases | Phase 3 | Recruiting | 2025 |
| Personalized CT guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in non atrial fibrillation patients after transcatheter aortic valve implantation a pragmatic international multicentre randomized clinical trial (POPular ATLANTIS trial) 2023-504637-42-01 — constriction, pathologic, aortic valve stenosis, hemorrhage, atrial fibrillation, aortic valve, transcatheter aortic valve replacement, therapeutics | Phase 4 | Recruiting | 2023 |
| European Registry of Transcatheter Repair for Tricuspid Regurgitation NCT06307262 — registries, heart valve diseases, heart diseases, heart failure, heart, tricuspid valve, tricuspid valve insufficiency, heart valves | N/A | Recruiting | 2023 |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI NCT05786131 — myocardial ischemia, coronary artery disease, myocardial infarction, percutaneous coronary intervention, arteries, st elevation myocardial infarction, coronary disease, non-st elevated myocardial infarction, wounds and injuries, ischemia | N/A | Recruiting | 2023 |
| Tendyne European Experience Registry NCT04898335 — registries, mitral valve, mitral valve insufficiency, transcatheter mitral valve replacement | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map